LSCC vs REGN · P/E 1085, rev $509.4M vs P/E 14, rev $14.34B
Lattice Semiconductor Corporation (LSCC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Lattice Semiconductor Corporation (LSCC) is a semiconductors company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported LSCC revenue for 2024-12-28 was $509.4M. Net income was $61.1M. Revenue was down 30.9% from 2023-12-30 to 2024-12-28. LSCC currently screens at market cap $20.81B and trailing P/E 1085.1.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
LSCC currently screens at market cap $20.81B and trailing P/E 1085.1. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the LSCC and REGN stock pages for the full models.
Not investment advice.